Epilepsy & Seizures

Filter Your Results

 

News

 

The Benefits of Collaborative Care

Paul G. Matthew, MD, DNBPAS, FAAN, FAHS

March/April 2018— The National Academy of Medicine defines team-based care as any provision of health care by 2 or more medical professionals, who work collaboratively across settings, to a…

News

March/April 2018—Lawful Physician-Hastened Death, Hearing Loss and Cognitive Impairment, Extended-Release Amantadine, Fibromyalgia Biomarkers, Phase 3 Trial of Rimegepant for Migraine, A Blood Test for Concussion, and more.

Results From Cannabidiol Dose-Ranging Safety Trial for Treating Patients With Dravet Syndrome

Wednesday, March 14, 2018—Previous randomized controlled trials have suggested that orally administered cannabidiol (CBD) is effective as an add-on to existing antiepileptic drugs (AEDs) for the treatm…

Pediatricians, Pediatric Neurologists, Patient Advocates, and Industry Partner to Create High-Tech Risk-Screening Tool for Children with Epilepsy

Tuesday, February 13, 2018—Digital Health Solutions (DHS), the Child Neurology Foundation (CNF), and Greenwich Biosciences began a collaborative effort to develop a digital tool that will prompt provide…

Food and Drug Administration Grants Breakthrough Therapy Designation for ZX008 for Treatment of Dravet Syndrome

Tuesday, February 06, 2018—Low-dose fenfluramine (ZX008, Zogenix) is classified as an orphan drug for the treatment of two rare forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome. Positive r…

FDA Filing for Cannabidiol, Data on Diet and Exercise and Brain Aging and Memory, Boston Scientific Indication for DBS

January 2018—FDA Accepts NDA Filing of First Cannabis Plant-Derived Medicine On December 28, 2017, GW Pharmaceuticals announced that the US Food and Drug Administration (FDA) had accept…

Anti-Leucine–Rich Glioma-Inactivated 1 Antibody Encephalitis

Michelle L. Dougherty, MD

January 2018— Leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis is a recently described syndrome primarily characterized by seizures and cognitive decline. LGI1 antibody en…

ECTRIMS Data Signal Renewed Emphasis on Multiple Sclerosis Disease Progression, Disability

November/December 2017—Data presented at the Seventh Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) -- Americas Committee for Treatment and Research in Multipl…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC